Simvastatin in non-insulin-dependent diabetes mellitus: Effect on serum lipids, lipoproteins and haemostatic measures

Diabetes Research and Clinical Practice

Volumn 23, Issue 2, 1994, Pages 111-119

  Farrer, Martyn ^a   Winocour, Peter H ^a   Evans, Kevin ^a   Neil, H Andrew W ^a   Laker, Michael F ^a   Kesteven, Patrick ^a   Alberti, K George M M ^a  

^a Department of Medicine ^*  (United Kingdom)

Author keywords

3 Hydroxy 3 methyl glutaryl coenzyme A reductase inhibitor; Blood glucose control; Haemostasis; Insulinaemia; Lipids; Lipoprotein composition; Non insulin dependent diabetes

Indexed keywords

APOLIPOPROTEIN A; APOLIPOPROTEIN B; BLOOD CLOTTING FACTOR 7; BLOOD CLOTTING FACTOR 8; C PEPTIDE; CHOLESTEROL; FIBRINOGEN; GLUCOSE; GLYCOSYLATED HEMOGLOBIN; INSULIN; LOW DENSITY LIPOPROTEIN; SIMVASTATIN; SULFONYLUREA DERIVATIVE;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIET; DOUBLE BLIND PROCEDURE; FEMALE; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTRIGLYCERIDEMIA; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS;

ADULT; AGED; ANTILIPEMIC AGENTS; APOLIPOPROTEINS B; BLOOD GLUCOSE; CHOLESTEROL, LDL; DIABETES MELLITUS, TYPE 2; DOUBLE-BLIND METHOD; FEMALE; HEMOSTASIS; HUMANS; HYPERCHOLESTEROLEMIA; LIPIDS; LIPOPROTEINS; LOVASTATIN; MALE; MIDDLE AGED; SIMVASTATIN; TRIGLYCERIDES;

EID: 0028301570     PISSN: 01688227     EISSN: None     Source Type: Journal    
DOI: 10.1016/0168-8227(94)90018-3     Document Type: Article

References (39)

1. Role of cardiovascular risk factors in prevention and treatment of macrovascular disease in diabetes
2. Morbidity and mortality in diabetes in the Framingham population. Sixteen year follow up study
3. Incidence of macrovascular disease in diabetes mellitus: the London cohort of the WHO Multinational Study of Vascular Disease in Diabetics
4. Impact of cardiovascular risk factors on coronary heart disease and mortality among middle aged diabetic men: a general population study
5. The role of circulating glucose and triglyceride concentrations and their interaction with other ‘risk factors’ as determinants of arterial disease in nine diabetic populations from the WHO multinational study
6. Hypertriglyceridaemia as a risk factor of coronary heart disease mortality in subjects with impaired glucose tolerance or diabetes. Results from the 11-year follow-up of the Paris prospective study
7. Risk factors for macrovascular disease in diabetes mellitus: the London follow-up to the WHO multinational study of vascular disease in diabetics
8. The Prospective Cardiovascular Munster (PROCAM) study: Prevalence of hyperlipidaemia in persons with hypertension and/or diabetes mellitus and the relation to coronary heart disease
9. Plasma lipids and diabetes mellitus in an adult community
10. Dyslipidemia in Type II Diabetes. Implications for therapeutic intervention
11. Drug treatment for diabetic dyslipoproteinaemia: a practical approach
12. Recommendation for strict control of plasma triglyceride in diabetic subjects
13. Diabetes, fibrinogen, and the risk of cardiovascular disease: The Framingham experience
14. Activation of coagulation in diabetes mellitus in relation to the presence of vascular complications
15. Haemostatic variables associated with diabetes mellitus and its complications
16. Plasma fibrinogen: a major coronary risk factor
17. Haemostatic function and ischaemic heart disease: principal results of the Northwick Park Study
18. Fibrinogen as a Risk Factor for Stroke and Myocardial Infarction
19. Comparative effects of simvastatin and cholestyramine in treatment of patients with hypercholesterolaemia
20. Improvement in the regulation of cellular cholesterologenesis in diabetes: the effect of reduction in serum cholesterol by simvastatin
21. Cholesterol lowering effects of simvastatin in patients with non-insulin dependent diabetes mellitus
22. Long term effects of low dose simvastatin in hypercholesterolaemic Type 2 diabetic patients
23. Simvastatin reduces plasma lipid levels and improves insulin action in elderly non-insulin dependent diabetics
24. Long-term treatment of hypercholesterolaemic non-insulin dependent diabetics (NIDDM) with pravastatin (CS-514)
25. Lovastatin for lowering cholesterol levels in non-insulin-dependent diabetes mellitus
26. Simvastatin in severe hypercholesterolaemia: a placebo controlled trial
27. Effect of lovastatin on hemorheology in type II hyperlipoproteinemia
28. Hemorheologic and coagulative pattern in hypercholesterolemic subjects treated with lipid-lowering drugs
29. Within-clinic reagent strip lipid measurement
30. Critical variables in the radioimmunoassay of serum insulin using the double antibody technic
31. Radioimmunological determination of human C-peptide in serum
32. Estimation of serum low density lipoprotein without use of preparative ultracentrifuge
33. Gerinnungsphysiologische schnell methode zur bestimmung des fibrinogens
34. A comparison of three methods of measuring serum high density lipoprotein cholesterol in diabetics and non-diabetics
35. Influence of lovastatin on concentrations and composition of lipoprotein subfractions
36. Lipoprotein metabolism in diabetes mellitus
37. Interrelationship of plasma triglyceride and coagulant factor VII levels in normotriglyceridemic hypercholesterolemia